Research suggests that gut dysbiosis may be a risk factor for immunoresistance in oncology. Studies are exploring the relationship between the gut microbiome and various aspects of cancer, including treatment response and disease progression. The gut microbiome's role in cancer is being investigated through various studies, including those on breast cancer, leukemia, and other conditions.